Cargando…

Corporate social responsibility in countries with mature and emerging pharmaceutical sectors

In recent decades the concept of Corporate Social Responsibility (CSR) has been adopted by many business sectors, including the pharmaceutical industry. However, in this and other sectors its application remains variable, particularly between mature and developing economies. Its stakeholders include...

Descripción completa

Detalles Bibliográficos
Autores principales: Volodina, Anna, Sax, Sylvia, Anderson, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134841/
https://www.ncbi.nlm.nih.gov/pubmed/25136398
_version_ 1782330921506045952
author Volodina, Anna
Sax, Sylvia
Anderson, Stuart
author_facet Volodina, Anna
Sax, Sylvia
Anderson, Stuart
author_sort Volodina, Anna
collection PubMed
description In recent decades the concept of Corporate Social Responsibility (CSR) has been adopted by many business sectors, including the pharmaceutical industry. However, in this and other sectors its application remains variable, particularly between mature and developing economies. Its stakeholders include pharmacy and medical students, their attitude to the involvement of companies in socially responsible activities will be important determinants of public response to the industry. OBJECTIVE: To investigate the knowledge, attitudes and practices of senior medical and pharmacy students towards the CSR concept in the pharmaceutical sector in mature (Germany) and developing (Russia) markets. METHODS: A questionnaire survey was carried out among senior pharmacy and medical students during the summer semester 2008 in two Russian and one German university. In each country 120 questionnaires were distributed. The response rate was 95% in Russia and 93% in Germany. RESULTS: Although the relevance of CSR was widely acknowledged by the students, very few were aware of CSR practices currently performed by companies. The reputation of the pharmaceutical industry was generally poor: less than 15% of respondents gave credence to the information provided in advertisements and fully supported pricing strategies as well as policies towards the developing countries. When choosing an employer more than 90% of respondents consider the policies affecting an employee directly as pivotal. However, for a high proportion of students (59% in Russia and 64% in Germany) socially irresponsible behavior by companies has a significant negative impact. CONCLUSIONS: This paper identifies practices which students believe should be a part of the CSR programmes for the pharmaceutical industry, and also some that should be abandoned. It recommends that corporate communication on CSR should be expanded. Key differences are seen in perceptions of students in Germany and Russia towards the extent of irresponsible actions and the variation between them.
format Online
Article
Text
id pubmed-4134841
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-41348412014-08-18 Corporate social responsibility in countries with mature and emerging pharmaceutical sectors Volodina, Anna Sax, Sylvia Anderson, Stuart Pharm Pract (Granada) Original Research In recent decades the concept of Corporate Social Responsibility (CSR) has been adopted by many business sectors, including the pharmaceutical industry. However, in this and other sectors its application remains variable, particularly between mature and developing economies. Its stakeholders include pharmacy and medical students, their attitude to the involvement of companies in socially responsible activities will be important determinants of public response to the industry. OBJECTIVE: To investigate the knowledge, attitudes and practices of senior medical and pharmacy students towards the CSR concept in the pharmaceutical sector in mature (Germany) and developing (Russia) markets. METHODS: A questionnaire survey was carried out among senior pharmacy and medical students during the summer semester 2008 in two Russian and one German university. In each country 120 questionnaires were distributed. The response rate was 95% in Russia and 93% in Germany. RESULTS: Although the relevance of CSR was widely acknowledged by the students, very few were aware of CSR practices currently performed by companies. The reputation of the pharmaceutical industry was generally poor: less than 15% of respondents gave credence to the information provided in advertisements and fully supported pricing strategies as well as policies towards the developing countries. When choosing an employer more than 90% of respondents consider the policies affecting an employee directly as pivotal. However, for a high proportion of students (59% in Russia and 64% in Germany) socially irresponsible behavior by companies has a significant negative impact. CONCLUSIONS: This paper identifies practices which students believe should be a part of the CSR programmes for the pharmaceutical industry, and also some that should be abandoned. It recommends that corporate communication on CSR should be expanded. Key differences are seen in perceptions of students in Germany and Russia towards the extent of irresponsible actions and the variation between them. Centro de Investigaciones y Publicaciones Farmaceuticas 2009 2009-03-15 /pmc/articles/PMC4134841/ /pubmed/25136398 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Volodina, Anna
Sax, Sylvia
Anderson, Stuart
Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
title Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
title_full Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
title_fullStr Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
title_full_unstemmed Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
title_short Corporate social responsibility in countries with mature and emerging pharmaceutical sectors
title_sort corporate social responsibility in countries with mature and emerging pharmaceutical sectors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134841/
https://www.ncbi.nlm.nih.gov/pubmed/25136398
work_keys_str_mv AT volodinaanna corporatesocialresponsibilityincountrieswithmatureandemergingpharmaceuticalsectors
AT saxsylvia corporatesocialresponsibilityincountrieswithmatureandemergingpharmaceuticalsectors
AT andersonstuart corporatesocialresponsibilityincountrieswithmatureandemergingpharmaceuticalsectors